Updates

www.nureca.com Dated: August 11, 2026 BSE LIMITED NATIONAL STOCK EXCHANGE OF INDIA LIMITED Corporate Relations Department Listing Department Phiroze Jeejeebhoy Towers Exchange Plaza, 5th Floor, Plot no. C/1 Dalal Street, Fort G Block, Bandra Kurla Complex, Bandra (E) Mumbai-400001 Mumbai-400051 Scrip code: 543264 Scrip Code: NURECA Subject: Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (“PIT Regulations”) Dear Sir/Madam, This is to inform you that a designated person of the Company has acquired/purchased shares of the Company and, being a designated person, the transaction is covered under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015, read with the applicable provisions relating to automation of continual disclosures/system- driven disclosures under the said Regulations. The Company has duly checked the system-driven disclosure mechanism at the respective stock exchanges; however, the aforesaid transaction is presently not being reflected/captured under the system-driven disclosure mechanism although the entry of the designated person is duly reflected on the designated depository portal. Initially, the Company was of the view that the non-reflection of the transaction could be attributable to a possible delay in the internal/system processing. However, upon further verification, the Company communicated the matter to the respective stock exchange(s). As of date, no conclusive resolution to the issue has been received, and it appears that resolution of the same may take some further time. Accordingly as an abundant precaution and to ensure compliance with the applicable regulatory requirements, the Company is making the disclosure manually under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. The Company respectfully requests the Stock Exchange to kindly take the aforesaid disclosure on record and treat the same as compliance with the applicable disclosure requirements under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. The Company shall continue to coordinate with the respective stock exchange(s) regarding the issue and take such further steps, if any, once the system-driven disclosure mechanism is functional for the aforesaid transaction. NURECA LIMITED Correspondence Office: SCO 6-7-8, 1st Floor, Madhya Marg, Sector 9-D, Chandigarh, India - 160009 Registered Office: Andheri West B-205, Bldg -42, B wing, Dhanashree heights, Azad Nagar Sangam CHS, Andheri West, Mumbai – 400053 Phone No. +91-172-5292900, CIN: L24304MH2016PLC320868 www.nureca.com Kindly take the same on record. Thanking you, For Nureca Limited Nishu Kansal Company Secretary & Compliance Officer M. No.: A33372 NURECA LIMITED Correspondence Office: SCO 6-7-8, 1st Floor, Madhya Marg, Sector 9-D, Chandigarh, India - 160009 Registered Office: Andheri West B-205, Bldg -42, B wing, Dhanashree heights, Azad Nagar Sangam CHS, Andheri West, Mumbai – 400053 Phone No. +91-172-5292900, CIN: L24304MH2016PLC320868